Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan · Delayed Price · Currency is JPY 3,890.00
+15.00 (0.39%)
May 29, 2026, 3:30 PM JST
Kissei Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 13,779 | 15,610 | 14,449 | 13,680 | 16,507 |
Depreciation & Amortization | 4,644 | 4,615 | 4,254 | 4,109 | 3,730 |
Loss (Gain) From Sale of Assets | -701 | 3,110 | -80 | -63 | 35 |
Loss (Gain) From Sale of Investments | -17,376 | -11,999 | -9,119 | -13,133 | -16,161 |
Other Operating Activities | -368 | -4,427 | -1,893 | -5,799 | -2,672 |
Change in Accounts Receivable | -1,929 | -974 | -5,863 | 27 | 250 |
Change in Inventory | -542 | 1,316 | -3,480 | -3,810 | 1,130 |
Change in Accounts Payable | 2,059 | -291 | 275 | 513 | -3,804 |
Change in Unearned Revenue | -186 | - | - | - | - |
Change in Other Net Operating Assets | -865 | -439 | -220 | -2,203 | 2,518 |
Operating Cash Flow | -1,485 | 6,521 | -1,677 | -6,679 | 1,533 |
Capital Expenditures | -4,883 | -4,507 | -1,201 | -2,103 | -1,489 |
Sale of Property, Plant & Equipment | 3,379 | 519 | 175 | 78 | 23 |
Sale (Purchase) of Intangibles | -753 | -523 | -632 | -444 | -430 |
Investment in Securities | 19,943 | 13,091 | 9,502 | 13,031 | 16,391 |
Other Investing Activities | -188 | -3,627 | 844 | -4,564 | -3,741 |
Investing Cash Flow | 17,500 | 4,952 | 8,690 | 6,001 | 10,776 |
Short-Term Debt Issued | 170 | 170 | - | - | - |
Total Debt Issued | 170 | 170 | - | - | - |
Short-Term Debt Repaid | -200 | -230 | -150 | -150 | -90 |
Long-Term Debt Repaid | -166 | - | - | - | -13 |
Total Debt Repaid | -366 | -230 | -150 | -150 | -103 |
Net Debt Issued (Repaid) | -196 | -60 | -150 | -150 | -103 |
Repurchase of Common Stock | -5,217 | -5,293 | -6,000 | - | - |
Common Dividends Paid | -4,841 | -3,801 | -3,722 | -3,135 | -2,536 |
Other Financing Activities | -1 | -171 | -134 | -135 | -117 |
Financing Cash Flow | -10,255 | -9,325 | -10,006 | -3,420 | -2,756 |
Foreign Exchange Rate Adjustments | 52 | 27 | -3 | -21 | 4 |
Miscellaneous Cash Flow Adjustments | 1 | 96 | -1 | -1 | - |
Net Cash Flow | 5,813 | 2,271 | -2,997 | -4,120 | 9,557 |
Free Cash Flow | -6,368 | 2,014 | -2,878 | -8,782 | 44 |
Free Cash Flow Margin | -6.54% | 2.28% | -3.81% | -13.01% | 0.07% |
Free Cash Flow Per Share | -153.22 | 46.17 | -63.59 | -190.44 | 0.95 |
Cash Interest Paid | 29 | 22 | 18 | 20 | 23 |
Cash Income Tax Paid | 3,363 | 4,357 | 1,834 | 5,699 | 2,567 |
Levered Free Cash Flow | 82.75 | 2,448 | 200.38 | -7,654 | 3,843 |
Unlevered Free Cash Flow | 100.25 | 2,461 | 211.63 | -7,641 | 3,858 |
Change in Working Capital | -1,463 | -388 | -9,288 | -5,473 | 94 |